Chison Cost Of Revenue from 2010 to 2024

688358 Stock   26.51  0.24  0.91%   
Chison Medical's Cost Of Revenue is increasing over the years with slightly volatile fluctuation. Cost Of Revenue is expected to dwindle to about 153.9 M. From 2010 to 2024 Chison Medical Cost Of Revenue quarterly data regression line had arithmetic mean of  113,241,819 and r-squared of  0.83. View All Fundamentals
 
Cost Of Revenue  
First Reported
2019-03-31
Previous Quarter
55.4 M
Current Value
43.4 M
Quarterly Volatility
12.8 M
 
Covid
Check Chison Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Chison Medical's main balance sheet or income statement drivers, such as Tax Provision of 11.9 M, Net Interest Income of 19.2 M or Interest Expense of 19.6 M, as well as many indicators such as . Chison financial statements analysis is a perfect complement when working with Chison Medical Valuation or Volatility modules.
  
This module can also supplement various Chison Medical Technical models . Check out the analysis of Chison Medical Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Chison Stock

Chison Medical financial ratios help investors to determine whether Chison Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Chison with respect to the benefits of owning Chison Medical security.